Статті в журналах з теми "Cerebrovascular disease - Social aspects"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Cerebrovascular disease - Social aspects".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Khasanova, D. R., T. V. Danilova, and Z. K. Latypova. "Epilepsy in patients with ischemic brain disease." Kazan medical journal 94, no. 2 (April 15, 2013): 235–39. http://dx.doi.org/10.17816/kmj1595.
Njomboro, Progress. "Social Cognition Deficits: Current Position and Future Directions for Neuropsychological Interventions in Cerebrovascular Disease." Behavioural Neurology 2017 (2017): 1–11. http://dx.doi.org/10.1155/2017/2627487.
Gayfullina, R. F., M. N. Katina, F. F. Rizvanova, O. A. Kravtsova, and A. A. Rizvanov. "Role of genetic polymorphism in the pathogenesis of cerebrovascular disease." Kazan medical journal 93, no. 4 (August 15, 2012): 663–67. http://dx.doi.org/10.17816/kmj1567.
Olari, M., G. Le Vacon, and M. Follet. "Ekbom syndrome - cultural aspects from a clinical case." European Psychiatry 26, S2 (March 2011): 471. http://dx.doi.org/10.1016/s0924-9338(11)72178-2.
Sasse, Kent. "Prognostic Scoring Systems: Facing Difficult Decisions with Objective Data." Cambridge Quarterly of Healthcare Ethics 2, no. 2 (1993): 185–91. http://dx.doi.org/10.1017/s096318010000089x.
Fang, Lingling, Jia Huang, Qian Zhang, Raymond C. K. Chan, Rong Wang, and Weiqing Wan. "Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes." Journal of Neurosurgery 125, no. 2 (August 2016): 299–307. http://dx.doi.org/10.3171/2015.7.jns142666.
M., Sarin S., and Jayasree A. K. "Health problems in geriatric population of age group ≥70 years in rural Kerala, India: a cross sectional study." International Journal of Research in Medical Sciences 7, no. 9 (August 27, 2019): 3486. http://dx.doi.org/10.18203/2320-6012.ijrms20193933.
Allenov, Andrey M., Tatyana P. Vasilyeva, Ivan V. Starostin, Ekaterina V. Makarova, and Anna V. Vorobeva. "Factors that determine the professional longevity of researchers." Russian Journal of Occupational Health and Industrial Ecology 61, no. 6 (August 7, 2021): 385–401. http://dx.doi.org/10.31089/1026-9428-2021-61-6-385-401.
Schwartz, Joseph A. "Neurobehavioral Aspects of Cerebrovascular Disease." Psychosomatics 33, no. 3 (August 1992): 358. http://dx.doi.org/10.1016/s0033-3182(92)71981-1.
Alberts, M. J. "Genetic aspects of cerebrovascular disease." Stroke 22, no. 2 (February 1991): 276–80. http://dx.doi.org/10.1161/01.str.22.2.276.
Neuren, A. P. "Neurobehavioral Aspects of Cerebrovascular Disease." Neurology 41, no. 12 (December 1, 1991): 2016. http://dx.doi.org/10.1212/wnl.41.12.2016.
Folstein, Marshal F. "Neurobehavioral Aspects of Cerebrovascular Disease." Journal of Nervous and Mental Disease 181, no. 2 (February 1993): 141. http://dx.doi.org/10.1097/00005053-199302000-00016.
Toole, James F. "Neurobehavioral aspects of cerebrovascular disease." Journal of the Neurological Sciences 108, no. 1 (March 1992): 118. http://dx.doi.org/10.1016/0022-510x(92)90198-t.
Marshall, J. "BOOK REVIEWS: Neurobehavioural Aspects of Cerebrovascular Disease." Journal of Neurology, Neurosurgery & Psychiatry 54, no. 12 (December 1, 1991): 1125–26. http://dx.doi.org/10.1136/jnnp.54.12.1125-a.
Shovlin, C. L. "Genetic Aspects of Cerebrovascular Malformations." Interventional Neuroradiology 6, no. 2 (June 2000): 107–11. http://dx.doi.org/10.1177/159101990000600204.
Kim, I. V., E. V. Bochkareva, and Yu Ya Varakin. "Cerebrovascular disease screening in general medical practice: methodological aspects." Profilakticheskaya meditsina 20, no. 5 (2017): 59. http://dx.doi.org/10.17116/profmed201720559-64.
Pula, John H., and Carlen A. Yuen. "Eyes and stroke: the visual aspects of cerebrovascular disease." Stroke and Vascular Neurology 2, no. 4 (July 6, 2017): 210–20. http://dx.doi.org/10.1136/svn-2017-000079.
Catto, A. J. "Genetic aspects of the hemostatic system in cerebrovascular disease." Neurology 57, Supplement 2 (September 1, 2001): S24—S30. http://dx.doi.org/10.1212/wnl.57.suppl_2.s24.
Hennerici, Michael G. "New Aspects of Calcium Antagonists for Treatment of Cerebrovascular Disease." Journal of Cardiovascular Pharmacology 18 (1991): S59—S63. http://dx.doi.org/10.1097/00005344-199106191-00011.
Hennerici, Michael G. "New Aspects of Calcium Antagonists for Treatment of Cerebrovascular Disease." Journal of Cardiovascular Pharmacology 18 (1991): S59—S63. http://dx.doi.org/10.1097/00005344-199118101-00011.
Magalhães, Nathalia Noyma Sampaio, Tássia Mariana Moreira da Paz, Renato Lourenço de Medeiros, Thais Sette Espósito, Olivia Franco dos Santos, Ianka Cristina Ernesto, Marina Schuffner Silva, and Daniela de Oliveira Werneck Rodrigues. "Doença Cerebrovascular: Aspectos de uma população com Doença Falciforme / Cerebrovascular Disease: Aspects of a population with sickle cell disease." Brazilian Journal of Health Review 3, no. 5 (2020): 15440–50. http://dx.doi.org/10.34119/bjhrv3n5-320.
Ladurner, G., M. Tschinkel, H. Klebl, and H. Lytwin. "Reaction time in cerebrovascular disease." Archives of Gerontology and Geriatrics 4, no. 4 (January 1985): 373–79. http://dx.doi.org/10.1016/0167-4943(85)90044-5.
Grotta, James C. "Clinical Aspects of the Use of Calcium Antagonists in Cerebrovascular Disease." Clinical Neuropharmacology 14, no. 5 (October 1991): 373–90. http://dx.doi.org/10.1097/00002826-199110000-00001.
Griessenauer, Christoph J., Sean Farrell, Atom Sarkar, Ramin Zand, Vida Abedi, Neil Holland, Andrew Michael, et al. "Genetic susceptibility to cerebrovascular disease: A systematic review." Journal of Cerebral Blood Flow & Metabolism 38, no. 11 (September 5, 2018): 1853–71. http://dx.doi.org/10.1177/0271678x18797958.
Levy, E. I., A. S. Boulos, B. R. Bendok, M. B. Horowitz, S. H. Kim, A. I. Qureshi, L. R. Guterman, and L. N. Hopkins. "Intracranial Stenting for Cerebrovascular Pathology." Rivista di Neuroradiologia 16, no. 1 (February 2003): 139–48. http://dx.doi.org/10.1177/197140090301600118.
Maslarov, D., D. Drenska, and J. Petrova. "Early Cerebrovascular Disease—Clinical Characteristics and Aspects. Description of a Clinical Case." American Journal of Neuroprotection and Neuroregeneration 2, no. 1 (June 1, 2010): 71–77. http://dx.doi.org/10.1166/ajnn.2010.1013.
Berrios, G. E. "Presbyophrenia: Clinical Aspects." British Journal of Psychiatry 147, no. 1 (July 1985): 76–79. http://dx.doi.org/10.1192/bjp.147.1.76.
Reisberg, Barry, Steven H. Ferris, Thet Oo, and Emile Franssen. "Staging: Relevance for Trial Design in Vascular Burden of the Brain." International Psychogeriatrics 15, S1 (July 2003): 231–39. http://dx.doi.org/10.1017/s1041610203009256.
Nance, Martha A. "Huntington Disease: Clinical, Genetic, and Social Aspects." Journal of Geriatric Psychiatry and Neurology 11, no. 2 (July 1998): 61–70. http://dx.doi.org/10.1177/089198879801100204.
King, Kathleen B. "Psychologic and social aspects of cardiovascular disease." Annals of Behavioral Medicine 19, no. 3 (September 1997): 264–70. http://dx.doi.org/10.1007/bf02892290.
Fukunishi, Isao, Takayuki Aoki, and Takashi Hosaka. "Correlations for Social Support with Depression in the Chronic Poststroke Period." Perceptual and Motor Skills 85, no. 3 (December 1997): 811–18. http://dx.doi.org/10.2466/pms.1997.85.3.811.
Keller, Sarah A., Kellia J. Hansmann, W. Ryan Powell, Barbara B. Bendlin, and Amy J. H. Kind. "A Scoping Review of the Association of Social Disadvantage and Cerebrovascular Disease Confirmed by Neuroimaging and Neuropathology." International Journal of Environmental Research and Public Health 18, no. 13 (July 2, 2021): 7071. http://dx.doi.org/10.3390/ijerph18137071.
Puddu, Paolo, Giovanni M. Puddu, Luciana Bastagli, Giorgio Massarelli, and Antonio Muscari. "Coronary and cerebrovascular atherosclerosis: two aspects of the same disease or two different pathologies?" Archives of Gerontology and Geriatrics 20, no. 1 (January 1995): 15–22. http://dx.doi.org/10.1016/0167-4943(94)00600-c.
Ramasubbu, Rajamannar, and Sidney H. Kennedy. "Factors Complicating the Diagnosis of Depression in Cerebrovascular Disease, Part I — Phenomenological and Nosological Issues*." Canadian Journal of Psychiatry 39, no. 10 (December 1994): 596–600. http://dx.doi.org/10.1177/070674379403901003.
Gaab, M. R., K. Holl, M. N. Nemati, E. Rzesacz, H. Becker, and H. Dietz. "Mapping of rCBF and cerebrovascular reserve capacity by stable xenon CT in cerebrovascular disease: Pathophysiological aspects and effects of operative therapy." Psychiatry Research 29, no. 3 (September 1989): 309–12. http://dx.doi.org/10.1016/0165-1781(89)90074-7.
Pokharel, Babu Ram, P. Pant, R. Gurung, R. Koju, TRS Bedi, and M. Pathak. "Study of Cerebrovascular Disease at Dhulikhel Hospital." Nepalese Heart Journal 7, no. 1 (August 25, 2013): 40–43. http://dx.doi.org/10.3126/njh.v7i1.8501.
Grimes, D. S. "Vitamin D and the social aspects of disease." QJM 104, no. 12 (August 3, 2011): 1065–74. http://dx.doi.org/10.1093/qjmed/hcr128.
Reed, Wornie. "Social Aspects of Illness, Disease and Sickness Absence." Contemporary Sociology: A Journal of Reviews 41, no. 5 (September 2012): 660–61. http://dx.doi.org/10.1177/0094306112457769dd.
Sockett, Paul. "Social and economic aspects of food-borne disease." Food Policy 18, no. 2 (April 1993): 110–19. http://dx.doi.org/10.1016/0306-9192(93)90019-8.
Oliveira, Carolina Camargo de, Sylvia Maria Ciasca, and M. Valeriana L. Moura-Ribeiro. "Stroke in patients with sickle cell disease: clinical and neurological aspects." Arquivos de Neuro-Psiquiatria 66, no. 1 (March 2008): 30–33. http://dx.doi.org/10.1590/s0004-282x2008000100008.
Strickland, Sidney. "Impact of the Coagulation System on the Pathogenesis of Alzheimer's Disease." Blood 130, Suppl_1 (December 7, 2017): SCI—3—SCI—3. http://dx.doi.org/10.1182/blood.v130.suppl_1.sci-3.sci-3.
Harbaugh, Robert E., and Akash Agarwal. "Training Residents in Endovascular Neurosurgery." Neurosurgery 59, suppl_5 (November 1, 2006): S3–277—S3–281. http://dx.doi.org/10.1227/01.neu.0000237355.55265.03.
Di Napoli, Mario, and Imtiaz M. Shah. "Neuroinflammation and Cerebrovascular Disease in Old Age: A Translational Medicine Perspective." Journal of Aging Research 2011 (2011): 1–18. http://dx.doi.org/10.4061/2011/857484.
Kim, Min-Young, and Hosung Shin. "Effects of Periodontal Disease on Cardio-Cerebrovascular Disease: A Focus on Personal Income and Social Deprivation." Journal of Dental Hygiene Science 17, no. 4 (August 31, 2017): 375–81. http://dx.doi.org/10.17135/jdhs.2017.17.4.375.
Jeng, Jiann-Shing, and Ping-Keung Yip. "Epidemiology of cerebrovascular disease in the elderly in East Asia." Geriatrics and Gerontology International 4, s1 (September 2004): S198—S201. http://dx.doi.org/10.1111/j.1447-0594.2004.00199.x.
Rossi, A., R. Biancheri, E. Lanino, M. Faraci, R. Haupt, C. Micalizzi, and P. Tortori-Donati. "Neuroradiology of Pediatric Hemolymphoproliferative Disease." Rivista di Neuroradiologia 16, no. 2 (April 2003): 221–50. http://dx.doi.org/10.1177/197140090301600203.
Geltser, B. I., I. G. Kurpatov, V. N. Kotelnikov, and Yu V. Zayats. "Chronic obstructive pulmonary disease and cerebrovascular diseases: functional and clinical aspect of comorbidity." Terapevticheskii arkhiv 90, no. 3 (March 15, 2018): 81–88. http://dx.doi.org/10.26442/terarkh201890381-88.
Assari, Shervin, and Mohsen Bazargan. "Baseline Obesity Increases 25-Year Risk of Mortality due to Cerebrovascular Disease: Role of Race." International Journal of Environmental Research and Public Health 16, no. 19 (October 1, 2019): 3705. http://dx.doi.org/10.3390/ijerph16193705.
Furr, L. Allen. "Psycho-Social Aspects of Serious Renal Disease and Dialysis." Social Work in Health Care 27, no. 3 (June 2, 1998): 97–118. http://dx.doi.org/10.1300/j010v27n03_06.
Gertsev, V. N., A. N. Stoyanov, S. S. Mashchenko, and S. A. Antonenko. "New pathogenetic aspects of the relationship between some risk factors of cerebrovascular diseases and Parkinson’s disease." INTERNATIONAL NEUROLOGICAL JOURNAL, no. 7.109 (November 20, 2019): 37–42. http://dx.doi.org/10.22141/2224-0713.7.109.2019.183011.